Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis

Table 2

Survival analysis for major target ceRNAs using LOGpc.

Symbol	Dataset	HR	95% CI	value	Prognostic
CFL2	TCGA	1.3608	1.0137-1.8268	0.0403	Poor
ITGA5	GSE31056	2.6804	1.3752-5.2245	0.0038	Poor
ITGA5	TCGA	1.4878	1.1162-1.9832	0.0067	Poor
KDELC1	TCGA	1.4946	1.1212-1.9922	0.0061	Poor
KDELC1	GSE31056	2.1694	1.0960-4.2940	0.0262	Poor
NFIA	GSE65858	0.4627	0.2648-0.8086	0.0068	Good
PTX3	GSE31056	3.9765	2.0435-7.7379	<0.0001	Poor
PTX3	TCGA	1.3605	1.0103-1.8320	0.0426	Poor
RELT	TCGA	1.3554	1.0113-1.8165	0.0418	Poor